Silo Pharma, Inc.
SILO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,110 | $1,031 | -$1,031 | -$1,731 |
| Dep. & Amort. | $3 | -$3 | $3 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$416 | -$100 | -$609 | $810 |
| Other Non-Cash | $568 | -$2,214 | -$3 | $0 |
| Operating Cash Flow | -$955 | -$1,285 | -$1,640 | -$917 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$95 | $34 | -$34 | -$38 |
| Inv. Sales/Matur. | $0 | -$905 | $905 | $0 |
| Other Inv. Act. | $0 | $1,259 | $0 | $0 |
| Investing Cash Flow | -$95 | $388 | $871 | -$38 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $635 | $2,094 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $635 | $2,094 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$416 | $1,197 | -$769 | -$955 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,334 | $3,137 | $3,906 | $4,861 |
| End Cash | $3,918 | $4,334 | $3,137 | $3,906 |
| Free Cash Flow | -$955 | -$1,285 | -$1,640 | -$917 |